Search results
Results from the WOW.Com Content Network
The Neurophysiological Biomarker Toolbox (NBT) is an open source MATLAB toolbox for the computation and integration of neurophysiological biomarkers (e.g., biomarkers based on EEG or MEG recordings). [1] The NBT toolbox has so far been used in seven peer-reviewed research articles, and has a broad user base of more than 1000 users. [2]
The colored product can either be of the NBT/BCIP reaction reveals where the antibody is bound, or can be used in immunofluorescence. [ 1 ] The NBT/BCIP reaction is also used for colorimetric/ spectrophotometric activity assays of oxidoreductases .
The typical response to such a scenario is to add 0.5 to all cells in the contingency table, [1] [7] although this should not be seen as a correction as it introduces a bias to results. [5] It is suggested that the adjustment is made to all contingency tables, even if there are no cells with zero entries.
Simulations performed using FBA are computationally inexpensive and can calculate steady-state metabolic fluxes for large models (over 10,000 reactions) in a few seconds on modern personal computers. The related method of metabolic pathway analysis seeks to find and list all possible pathways between metabolites.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
In clinical practice, post-test probabilities are often just estimated or even guessed. This is usually acceptable in the finding of a pathognomonic sign or symptom, in which case it is almost certain that the target condition is present; or in the absence of finding a sine qua non sign or symptom, in which case it is almost certain that the target condition is absent.
In evidence-based medicine, likelihood ratios are used for assessing the value of performing a diagnostic test.They use the sensitivity and specificity of the test to determine whether a test result usefully changes the probability that a condition (such as a disease state) exists.
NBT (NBTB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.